Shareholders Foundation, Inc.

American Oriental Bioengineering, Inc. (PINK:AOBI) Investor Lawsuit Deadline on August 22

A Deadline is coming up on August 22, 2012 in the lawsuit for investors in American Oriental Bioengineering, Inc. (PINK:AOBI) and PINK:AOBI stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 08/01/2012 -- A deadline is coming up on August 22, 2012 in the lawsuit filed for investors of American Oriental Bioengineering, Inc. (PINK:AOBI) over alleged securities laws violations by American Oriental Bioengineering, Inc in connection with certain financial statements.

Investors with a substantial investment in American Oriental Bioengineering, Inc. (PINK:AOBI) shares between November 9, 2009 and June 15, 2012, should get active before the Deadline that is coming up on August 22, 2012, and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of American Oriental Bioengineering, Inc. (PINK:AOBI) between November 9, 2009 and June 15, 2012, that American Oriental Bioengineering, Inc. and certain of its present and former officers and directors violated the Securities Exchange Act of 1934 by issuing allegedly materially false and misleading financial statements and concealing the Company's material internal control weaknesses.

On June 15, 2012, American Oriental Bioengineering, Inc. announced that it dismissed Ernst & Young Hua Ming , as its independent registered public accounting firm.

American Oriental Bioengineering said that on June 15, 2012, it received a letter from Ernst & Young Hua Ming in which it withdrew its reports on the financial statements and related internal control over financial reporting for the years ended and as of December 31, 2009 and 2010 and accordingly, its reports issued thereto on March 15, 2010 and 2011 can no longer be relied upon. American Oriental Bioengineering said the inconsistencies Ernst & Young Hua Ming identified, which were not resolved at the time of its dismissal,

Shares of American Oriental Bioengineering, Inc. (PINK:AOBI) closed on July 31, 2012, at $042 per share.

Those who purchased shares of American Oriental Bioengineering, Inc. (PINK:AOBI) between November 9, 2009 and June 15, 2012, have certain options and there are strict and short deadlines running. Deadline: August 22, 2012. AOBI investors should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Jacob Rosenfeld
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com